InsidersTradesSigma
Discover the full record of transactions filed by Hamill John P., Chief Financial Officer. Officer active across 1 companies, notably Windtree Therapeutics INC. Aggregated, 1 filings have been published. The latest transaction was disclosed on 4 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
John P. Hamill is the Chief Financial Officer and Senior Vice President at Windtree Therapeutics Inc. He is responsible for the company's financial management, including budgeting and financial reporting. With expertise in finance, Hamill plays a key role in optimizing the company's financial performance.